|
|
 |
 |
|
|
|
- secure wrap foil overwrapping
helps lock out airborne viruses
and contaminants
- Bar coding on secure wrap
packaging and carton helps
eliminate dispensing errors and
associated costs
- Color coding on packaging helps avoid mix-ups with other medicines
- Embossed vials for quick identification and safe dispensing procedures
- TwistFlex® vials are patient-friendly, sterile, and tamper resistant
|
|
NAEPP Guidelines recommend Cromolyn Sodium as an anti-inflammatory therapy for the long-term treatment of children with mild persistent asthma1 |
|
|
|
Cromolyn Sodium Inhalation Solution USP is a prophylactic agent indicated in the management of patients with bronchial asthma.
Cromolyn Sodium Inhalation Solution USP has no role in the treatment of status asthmaticus. The most common adverse reactions associated with the use of Cromolyn Sodium Inhalation Solution USP are cough, nasal congestion, nausea, sneezing, and wheezing. Please see full prescribing information. |
|
|
|
| 49502-689-61 |
Cromolyn Sodium Inhalation Solution USP |
20 mg/2 mL |
2 |
60 |
|
|
|
|
1. NAEPP Quick Reference Expert Panel Report: Guidelines for the
Diagnosis and Management of Asthma, Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health. June 2002. NIH publication no. 02-5075.
*Comparison based on published average wholesale prices in Red Book, September 2003. AWP may not represent the actual price to pharmacist or consumers.
Intal® is a registered trademark of King Pharmaceuticals, Inc.
|
|
|
|
|
